» Authors » M Schabet

M Schabet

Explore the profile of M Schabet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 58
Citations 563
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pawlik G, Wagner B, Schabet M
Nervenarzt . 2011 Nov; 83(4):476-80. PMID: 22105884
Background: We wanted to compare the outcome following IV thrombolysis in our patients with ischemic stroke with the outcome reported from the phase 3 registration trials and other large trials....
2.
Schabet M
Klin Monbl Augenheilkd . 2010 Nov; 227(11):857-9. PMID: 21077017
The author reports his experience with his own case of Miller-Fisher syndrome (MFS) and discusses the spectrum of GQ 1b-positive oculomotor nerve diseases, including MFS, Bickerstaff's brainstem encephalitis, Guillain-Barré syndrome,...
3.
Herrlinger U, Steinbrecher A, Rieger J, Hau P, Kortmann R, Meyermann R, et al.
J Neurol . 2005 Sep; 252(3):291-9. PMID: 16189725
Adult medulloblastoma is a rare tumor with few retrospective studies published so far. The role of adjuvant chemotherapy or chemotherapy at relapse is unclear. This study reports therapy and outcome...
4.
Schabet M, Weinauer E
Fortschr Neurol Psychiatr . 2003 Dec; 71(12):667-82. PMID: 14661161
No abstract available.
5.
Kastrup A, Thomas C, Hartmann C, Schabet M
Headache . 2001 Jun; 38(8):608-13. PMID: 11398304
There is still some controversy about alterations in velocity of blood flow and in cerebral vasomotor reactivity of intracranial arteries in migraineurs during the interictal phase. By means of simultaneous...
6.
Streffer J, Bitzer M, Schabet M, Dichgans J, Weller M
Neurology . 2001 May; 56(9):1219-21. PMID: 11342692
Twelve patients with brain tumors and progressive edema caused by tumor progression or radiochemotherapy-related leukoencephalopathy were treated with H15, a phytotherapeutic anti-inflammatory agent. Edema was reduced in two of seven...
7.
Herrlinger U, Schabet M, Brugger W, Kortmann R, Kanz L, Bamberg M, et al.
Cancer . 2001 Jan; 91(1):130-5. PMID: 11148569
Background: This retrospective single-center study assesses the feasibility, therapeutic outcome, and late side effects of combined modality therapy with intravenous methotrexate, whole brain radiotherapy (WBRT), and intravenous cytarabine in patients...
8.
Streffer J, Schabet M, Bamberg M, Grote E, Meyermann R, Voigt K, et al.
J Neurol . 2000 Jun; 247(4):297-302. PMID: 10836623
Oligodendroglial tumors have been identified as a subgroup of glial neoplasms with a distinctly better response to chemotherapy and overall survival than purely astrocytic gliomas. Here we report our experience...
9.
Herrlinger U, Schabet M, Bitzer M, Petersen D, Krauseneck P
J Neurooncol . 1999 Nov; 43(3):219-26. PMID: 10563426
Immunocompetent patients with primary central nervous system lymphoma (PCNSL) present with a median age of 55 years, immunosuppressed patients with a median age of 40 years. They show a broad...
10.
Schabet M
J Neurooncol . 1999 Nov; 43(3):199-201. PMID: 10563423
In the beginning of the nineties the National Cancer Institute Surveillance, Epidemiology, and End Results Program calculated the incidence of primary central nervous system non-Hodgkin's lymphoma (PCNSL) as 1:100000. The...